Literature DB >> 16595789

The Siblings With Ischemic Stroke Study (SWISS): a progress report.

James F Meschia1, Brett M Kissela, Thomas G Brott, Robert D Brown, Bradford B Worrall, Jeanne Beck, Alexa N Skarp.   

Abstract

There is increasing evidence that genetic factors are associated with ischemic stroke, including multiple recent reports of association with the gene PDE4D, encoding phosphodiesterase 4D, on chromosome 5q12. Genetic studies of stroke are important but can be logistically difficult to perform. This article reviews the design of the Siblings With Ischemic Stroke Study (SWISS) and discusses problems in performing a sibling-based pedigree study where proband-initiated consent is used to enroll pedigree members. Proband-initiated enrollment optimizes privacy protections for family members, but it is associated with a substantial pedigree non-completion rate such that 3 to 4 probands must be identified to obtain one completed sibling pedigree. This report updates the progress of enrollment in the SWISS protocol, discusses barriers to pedigree completion and describes innovative approaches used by the SWISS investigators to enhance enrollment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595789      PMCID: PMC1435656          DOI: 10.3121/cmr.4.1.12

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  29 in total

Review 1.  The intrinsically unstable life of DNA triplet repeats associated with human hereditary disorders.

Authors:  R P Bowater; R D Wells
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

2.  Feasibility of an affected sibling pair study in ischemic stroke: results of a 2-center family history registry.

Authors:  J F Meschia; R D Brown; T G Brott; J Hardy; E J Atkinson; P C O'Brien
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

3.  Understanding the challenges in recruiting blacks to a longitudinal cohort study: the Adventist health study.

Authors:  Patti Herring; Susanne Montgomery; Antronette K Yancey; David Williams; Gary Fraser
Journal:  Ethn Dis       Date:  2004       Impact factor: 1.847

4.  Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines.

Authors:  M Sugimoto; T Ide; M Goto; Y Furuichi
Journal:  Mech Ageing Dev       Date:  1999-02-01       Impact factor: 5.432

5.  Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination.

Authors:  W J Jones; L S Williams; J F Meschia
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

6.  Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment.

Authors:  K P Madden; P N Karanjia; H P Adams; W R Clarke
Journal:  Neurology       Date:  1995-11       Impact factor: 9.910

7.  Creation of a bilingual Spanish-English version of the Questionnaire for Verifying Stroke-free Status.

Authors:  Pablo R Castillo; Thomas G Brott; Salvador Alvarez; James F Meschia
Journal:  Neuroepidemiology       Date:  2004 Sep-Oct       Impact factor: 3.282

8.  Reliability of the questionnaire for verifying stroke-free status.

Authors:  James F Meschia; Marc A Lojacono; Mary J Miller; Thomas G Brott; Elizabeth J Atkinson; Peter C O'Brien
Journal:  Cerebrovasc Dis       Date:  2003-12-29       Impact factor: 2.762

9.  Epstein-Barr virus transformation of human lymphoblastoid cells from patients with fragile X syndrome induces variable changes on CGG repeats size and promoter methylation.

Authors:  Victoria Bonilla; Francisco Sobrino; Miguel Lucas; Elizabeth Pintado
Journal:  Mol Diagn       Date:  2003

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  5 in total

1.  Defining the phosphodiesterase superfamily members in rat brain microvessels.

Authors:  Zhen He; Li Cui; Tucker A Patterson; Merle G Paule
Journal:  ACS Chem Neurosci       Date:  2011-06-27       Impact factor: 4.418

2.  Small vessel cerebrovascular disease: the past, present, and future.

Authors:  Réza Behrouz; Ali R Malek; Michel T Torbey
Journal:  Stroke Res Treat       Date:  2012-01-24

3.  Genome-wide analysis of blood pressure variability and ischemic stroke.

Authors:  Sunaina Yadav; Ioana Cotlarciuc; Patricia B Munroe; Mark Caulfield; Pankaj Sharma; Muhammad S Khan; Michael A Nalls; Steve Bevan; Yu-Ching Cheng; Wei-Min Chen; Rainer Malik; Nina S McCarthy; Elizabeth G Holliday; Douglas Speed; Nazeeha Hasan; Mateusz Pucek; Paul E Rinne; Peter Sever; Alice Stanton; Denis C Shields; Jane M Maguire; Mark McEvoy; Rodney J Scott; Luigi Ferrucci; Mary J Macleod; John Attia; Hugh S Markus; Michele M Sale; Bradford B Worrall; Braxton D Mitchell; Martin Dichgans; Cathy Sudlow; James F Meschia; Peter M Rothwell
Journal:  Stroke       Date:  2013-08-08       Impact factor: 7.914

4.  The Fangshan/Family-based Ischemic Stroke Study In China (FISSIC) protocol.

Authors:  Xun Tang; Yonghua Hu; Dafang Chen; Siyan Zhan; Zongxin Zhang; Huidong Dou
Journal:  BMC Med Genet       Date:  2007-09-10       Impact factor: 2.103

5.  Association of integrin alpha2 gene variants with ischemic stroke.

Authors:  Mar Matarin; W Mark Brown; John A Hardy; Stephen S Rich; Andrew B Singleton; Robert D Brown; Thomas G Brott; Bradford B Worrall; James F Meschia
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-30       Impact factor: 6.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.